Close Menu

NEW YORK (360Dx) — IGeneX said today that the New York State Department of Health has approved the company's Lyme disease detection assays.

The approval allows IGeneX to make the assays available to New York residents.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.